Cargando…
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) improve clinical outcomes in patients suffering from different types of cancer. Liver toxicity is one of the immune-related adverse events associated with immunotherapy; although not common, its management is challenging as it is extremely heterogeneous in terms o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648167/ https://www.ncbi.nlm.nih.gov/pubmed/33205034 http://dx.doi.org/10.1016/j.jhepr.2020.100170 |